The HPV Vaccine Prevents Cancer. Why Do Many Cancer Survivors Not Get It?
A recent study investigated why some young cancer survivors did not want the HPV vaccine and how they can be better served.
Progress Against Cancer
A recent study investigated why some young cancer survivors did not want the HPV vaccine and how they can be better served.
Drug shortage affects patients with advanced prostate cancer, and military pilots and ground crews have increased cancer rates.
How the latest clinical therapies are helping patients and laboratory research informing future treatments.
The FDA has approved the monoclonal antibody retifanlimab-dlwr for some patients with Merkel cell carcinoma. The U.S. Food and Drug Administration (FDA) has granted accelerated approval to retifanlimab-dlwr (Zynyz) for the treatment of adult...
Active monitoring is a viable choice for some with prostate cancer, and more news from the week selected by the editors of Cancer Today.
A targeted therapy regimen was approved to treat some children with brain cancer The U.S. Food and Drug Administration (FDA) has approved dabrafenib (Tafinlar) in combination with trametinib (Mekinist) for pediatric patients 1 year...
The 2020 death of actor Chadwick Boseman shocked the public, sparking grief in those who revered his portrayal of the Black Panther. It also raised questions about how a young man who appeared healthy...
The immune system is designed to operate like a well-oiled machine. With a myriad of distinct cell types, a handful of specialized organs, and a network of watchtowers spread throughout the body, the immune...
The FDA sets rule that requires mammography providers to notify women who have dense breasts, and more news selected by the editors of Cancer Today.
The FDA approved abemaciclib with endocrine therapy for HR-positive, HER2-negative, early-stage breast cancer at high risk of recurrence. The U.S. Food and Drug Administration (FDA) has approved abemaciclib (Verzenio) with endocrine therapy (tamoxifen or...
AACR Fellow Lewis C. Cantley, PhD, leads a national effort targeting triple-negative breast cancer and ovarian cancer with a novel drug combination.
Learn More